hVIVO CEO Mo Khan discusses the company's Asia Pacific breakthrough
Episode 1103, Jan 05, 2023, 07:29 AM
Mo Khan, chief executive of specialist contract research organisation hVivo, talks to Vox about the company's first order in Asia Pacific, a £5.2bn contract with a global biotechnology company to use hVivo's RSV Human Challenge Model to test vaccines against the potentially deadly respiratory disease - a deal which lays the foundation for major growth in the region.